Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arcutis Biotherapeutics, Inc. (ARQT) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Arcutis Biotherapeutics, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1787306.
Total stock buying since 2020: $66,422,679.
Total stock sales since 2020: $41,324,555.
Total stock option exercises since 2020: $677,177.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 13,734 | $184,863 | 279,982 | $4,026,204 | 66,000 | $0 |
| 2024 | 27,802 | $226,302 | 358,448 | $3,340,439 | 84,114 | $44,738 |
| 2023 | 81,463 | $209,333 | 68,415 | $978,355 | 93,525 | $157,205 |
| 2022 | 0 | $0 | 1,298,783 | $27,133,327 | 32,847 | $42,821 |
| 2021 | 0 | $0 | 144,037 | $4,184,117 | 95,610 | $158,733 |
| 2020 | 3,403,893 | $65,802,181 | 57,600 | $1,662,113 | 137,003 | $273,680 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-07 | Watanabe Todd Franklin (President and CEO) | Option Ex | 700 | 1.68 | 1,176 |
| 2022-03-07 | Lock Kenneth A. (Chief Commercial Officer) | Sale | 30 | 16.45 | 493 |
| 2022-03-07 | Turney Patricia A. (SVP, Operations) | Sale | 30 | 16.45 | 493 |
| 2022-03-07 | Burnett Patrick (See Remarks) | Sale | 30 | 16.45 | 493 |
| 2022-03-07 | Osborne David W (Chief Technical Officer) | Sale | 28 | 16.45 | 460 |
| 2022-03-04 | Burrows Scott L (Chief Financial Officer) | Sale | 293 | 16.86 | 4,939 |
| 2022-03-04 | Watanabe Todd Franklin (President and CEO) | Sale | 2,489 | 16.86 | 41,962 |
| 2022-03-04 | Lock Kenneth A. (Chief Commercial Officer) | Sale | 993 | 16.86 | 16,740 |
| 2022-03-04 | Turney Patricia A. (SVP, Operations) | Sale | 993 | 16.86 | 16,740 |
| 2022-03-04 | Burnett Patrick (See Remarks) | Sale | 981 | 16.86 | 16,538 |
| 2022-03-04 | Osborne David W (Chief Technical Officer) | Sale | 828 | 16.86 | 13,959 |
| 2022-03-01 | Burrows Scott L (Chief Financial Officer) | Sale | 420 | 17.75 | 7,456 |
| 2022-03-01 | Watanabe Todd Franklin (President and CEO) | Sale | 2,153 | 17.75 | 38,222 |
| 2022-03-01 | Lock Kenneth A. (Chief Commercial Officer) | Sale | 935 | 17.75 | 16,599 |
| 2022-03-01 | Turney Patricia A. (SVP, Operations) | Sale | 936 | 17.75 | 16,616 |
| 2022-03-01 | Osborne David W (Chief Technical Officer) | Sale | 775 | 17.75 | 13,758 |
| 2022-02-09 | Watanabe Todd Franklin (President and CEO) | Sale | 1,000 | 17.00 | 17,000 |
| 2022-02-09 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,000 | 1.68 | 1,681 |
| 2022-01-05 | Watanabe Todd Franklin (President and CEO) | Sale | 1,000 | 21.86 | 21,857 |
| 2022-01-05 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,000 | 1.68 | 1,681 |
| 2022-01-03 | Welgus Howard G. | Sale | 2,500 | 21.21 | 53,030 |
| 2022-01-03 | Welgus Howard G. | Option Ex | 2,500 | .58 | 1,450 |
| 2021-12-27 | Burrows Scott L (Chief Financial Officer) | Sale | 12,560 | 20.07 | 252,142 |
| 2021-12-23 | Welgus Howard G. (Director) | Sale | 2,500 | 20.16 | 50,395 |
| 2021-12-23 | Welgus Howard G. (Director) | Option Ex | 2,500 | .58 | 1,450 |
| 2021-12-08 | Watanabe Todd Franklin (President and CEO) | Sale | 1,000 | 17.00 | 17,000 |
| 2021-12-08 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,000 | 1.68 | 1,681 |
| 2021-11-05 | Watanabe Todd Franklin (President and CEO) | Sale | 1,000 | 21.50 | 21,502 |
| 2021-11-05 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,000 | 1.68 | 1,681 |
| 2021-11-01 | Welgus Howard G. | Sale | 2,500 | 21.81 | 54,525 |
| 2021-11-01 | Welgus Howard G. | Option Ex | 2,500 | .58 | 1,450 |
| 2021-10-05 | Watanabe Todd Franklin (President and CEO) | Sale | 2,500 | 24.92 | 62,292 |
| 2021-10-05 | Watanabe Todd Franklin (President and CEO) | Option Ex | 2,500 | 1.68 | 4,202 |
| 2021-10-01 | Watanabe Todd Franklin (President and CEO) | Sale | 1,500 | 25.01 | 37,510 |
| 2021-10-01 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,500 | 1.68 | 2,521 |
| 2021-10-01 | Welgus Howard G. | Sale | 2,500 | 23.87 | 59,680 |
| 2021-10-01 | Welgus Howard G. | Option Ex | 2,500 | .58 | 1,450 |
| 2021-09-07 | Watanabe Todd Franklin (President and CEO) | Sale | 1,000 | 21.14 | 21,137 |
| 2021-09-07 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,000 | 1.68 | 1,681 |
| 2021-09-01 | Welgus Howard G. | Sale | 5,000 | 20.99 | 104,955 |
| 2021-09-01 | Welgus Howard G. | Option Ex | 5,000 | 1.13 | 5,649 |
| 2021-08-05 | Watanabe Todd Franklin (President and CEO) | Sale | 1,000 | 20.81 | 20,810 |
| 2021-08-05 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,000 | 1.68 | 1,681 |
| 2021-07-06 | Watanabe Todd Franklin (President and CEO) | Sale | 1,750 | 26.58 | 46,515 |
| 2021-07-06 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,750 | 1.68 | 2,941 |
| 2021-07-01 | Welgus Howard G. | Sale | 2,200 | 26.45 | 58,194 |
| 2021-07-01 | Welgus Howard G. | Option Ex | 2,200 | 3.29 | 7,246 |
| 2021-06-25 | Chaudhuri Bhaskar | Sale | 6,755 | 27.50 | 185,762 |
| 2021-06-24 | Chaudhuri Bhaskar | Sale | 729 | 27.50 | 20,047 |
| 2021-06-21 | Chaudhuri Bhaskar | Sale | 2,516 | 27.50 | 69,190 |
| 2021-06-07 | Watanabe Todd Franklin (President and CEO) | Sale | 1,750 | 26.35 | 46,112 |
| 2021-06-07 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,750 | 1.68 | 2,941 |
| 2021-06-01 | Welgus Howard G. | Sale | 2,200 | 27.33 | 60,130 |
| 2021-06-01 | Welgus Howard G. | Option Ex | 2,200 | 3.29 | 7,246 |
| 2021-06-01 | Chaudhuri Bhaskar | Sale | 10,000 | 27.50 | 275,000 |
| 2021-05-21 | Welgus Howard G. | Option Ex | 1,612 | 1.13 | 1,821 |
| 2021-05-07 | Watanabe Todd Franklin (President and CEO) | Sale | 750 | 35.00 | 26,250 |
| 2021-05-07 | Watanabe Todd Franklin (President and CEO) | Option Ex | 750 | 1.68 | 1,260 |
| 2021-05-05 | Watanabe Todd Franklin (President and CEO) | Sale | 1,750 | 34.00 | 59,500 |
| 2021-05-05 | Watanabe Todd Franklin (President and CEO) | Option Ex | 1,607 | 1.68 | 2,701 |
| 2021-04-30 | Watanabe Todd Franklin (President and CEO) | Sale | 1,500 | 35.00 | 52,500 |
| 2021-04-20 | Chaudhuri Bhaskar | Sale | 10,000 | 28.26 | 282,580 |
| 2021-04-16 | Welgus Howard G. | Option Ex | 2,655 | 1.31 | 3,488 |
| 2021-04-05 | Watanabe Todd Franklin (President and CEO) | Sale | 1,750 | 29.93 | 52,377 |
| 2021-04-01 | Welgus Howard G. | Sale | 2,200 | 29.50 | 64,911 |
| 2021-04-01 | Welgus Howard G. | Option Ex | 2,200 | 3.29 | 7,246 |
| 2021-03-22 | Chaudhuri Bhaskar | Sale | 10,000 | 31.10 | 311,030 |
| 2021-03-16 | Welgus Howard G. | Option Ex | 2,653 | 1.31 | 3,486 |
| 2021-03-10 | Smither John W (Chief Financial Officer) | Sale | 1,750 | 32.90 | 57,575 |
| 2021-03-10 | Smither John W (Chief Financial Officer) | Option Ex | 500 | 1.68 | 840 |
| 2021-03-05 | Watanabe Todd Franklin (President and CEO) | Sale | 1,750 | 30.55 | 53,462 |
| 2021-03-04 | Smither John W (Chief Financial Officer) | Option Ex | 12,396 | 1.68 | 20,837 |
| 2021-03-02 | Watanabe Todd Franklin (President and CEO) | Sale | 2,107 | 35.19 | 74,136 |
| 2021-03-01 | Welgus Howard G. | Sale | 2,200 | 34.60 | 76,131 |
| 2021-03-01 | Welgus Howard G. | Option Ex | 2,200 | 3.29 | 7,246 |
| 2021-03-01 | Lock Kenneth A. (Chief Commercial Officer) | Sale | 933 | 34.20 | 31,907 |
| 2021-03-01 | Turney Patricia A. (SVP, Operations) | Sale | 934 | 34.52 | 32,241 |
| 2021-03-01 | Smither John W (Chief Financial Officer) | Sale | 773 | 34.20 | 26,439 |
| 2021-03-01 | Osborne David W (Chief Technical Officer) | Sale | 780 | 34.57 | 26,967 |
| 2021-02-22 | Chaudhuri Bhaskar | Sale | 10,000 | 35.66 | 356,580 |
| 2021-02-16 | Welgus Howard G. | Option Ex | 2,654 | 1.31 | 3,487 |
| 2021-02-10 | Smither John W (Chief Financial Officer) | Sale | 2,750 | 35.64 | 98,010 |
| 2021-02-10 | Smither John W (Chief Financial Officer) | Option Ex | 750 | 1.68 | 1,260 |
| 2021-02-05 | Watanabe Todd Franklin (President and CEO) | Sale | 10,000 | 34.13 | 341,270 |
| 2021-02-05 | Watanabe Todd Franklin (President and CEO) | Option Ex | 10,000 | 1.68 | 16,810 |
| 2021-02-04 | Welgus Howard G. | Option Ex | 19,861 | 1.68 | 33,386 |
| 2021-02-01 | Welgus Howard G. | Sale | 2,200 | 34.74 | 76,432 |
| 2021-02-01 | Welgus Howard G. | Option Ex | 2,200 | 1.68 | 3,698 |
| 2021-02-01 | Smither John W (Chief Financial Officer) | Sale | 5,000 | 35.00 | 175,000 |
| 2021-02-01 | Smither John W (Chief Financial Officer) | Option Ex | 1,250 | 1.68 | 2,101 |
| 2021-02-01 | Chaudhuri Bhaskar | Sale | 9,949 | 33.25 | 330,804 |
| 2021-01-29 | Chaudhuri Bhaskar | Sale | 51 | 27.50 | 1,402 |
| 2021-01-19 | Smither John W (Chief Financial Officer) | Sale | 1,750 | 30.00 | 52,500 |
| 2021-01-19 | Smither John W (Chief Financial Officer) | Option Ex | 500 | 1.68 | 840 |
| 2021-01-12 | Welgus Howard G. | Option Ex | 1,222 | .58 | 708 |
| 2021-01-04 | Welgus Howard G. | Sale | 2,200 | 27.82 | 61,215 |
| 2021-01-04 | Welgus Howard G. | Option Ex | 2,200 | 1.68 | 3,698 |
| 2020-12-14 | Welgus Howard G. | Option Ex | 1,222 | .58 | 708 |
| 2020-12-14 | Smither John W (Chief Financial Officer) | Sale | 5,250 | 30.00 | 157,500 |
| 2020-12-14 | Smither John W (Chief Financial Officer) | Option Ex | 1,500 | 1.68 | 2,521 |
| 2020-12-14 | Osborne David W (Chief Technical Officer) | Sale | 15,000 | 30.00 | 450,000 |
| 2020-12-01 | Welgus Howard G. | Sale | 2,200 | 26.28 | 57,824 |
| 2020-12-01 | Welgus Howard G. | Option Ex | 2,200 | 1.68 | 3,696 |
| 2020-11-12 | Welgus Howard G. | Option Ex | 1,222 | .58 | 708 |
| 2020-11-02 | Welgus Howard G. | Sale | 2,200 | 18.27 | 40,185 |
| 2020-11-02 | Welgus Howard G. | Option Ex | 2,200 | 1.68 | 3,696 |
| 2020-10-26 | Lock Kenneth A. (Chief Commercial Officer) | Option Ex | 2,668 | 6.52 | 17,395 |
| 2020-10-22 | Lock Kenneth A. (Chief Commercial Officer) | Option Ex | 2,695 | 6.52 | 17,571 |
| 2020-10-15 | Welgus Howard G. | Option Ex | 1,222 | .58 | 708 |
| 2020-10-15 | Lock Kenneth A. (Chief Commercial Officer) | Option Ex | 7,500 | 6.52 | 48,900 |
| 2020-10-02 | Orbimed Capital Gp Vii Llc | Buy | 496,000 | 25.00 | 12,400,000 |
| 2020-10-02 | Silverstein Jonathan | Buy | 496,000 | 25.00 | 12,400,000 |
| 2020-10-01 | Welgus Howard G. | Sale | 2,200 | 26.68 | 58,698 |
| 2020-10-01 | Welgus Howard G. | Option Ex | 2,200 | 1.68 | 3,696 |
| 2020-09-29 | Watanabe Todd Franklin (President and CEO) | Sale | 6,000 | 30.00 | 180,000 |
| 2020-09-29 | Watanabe Todd Franklin (President and CEO) | Option Ex | 6,000 | 1.68 | 10,086 |
| 2020-09-29 | Smither John W (Chief Financial Officer) | Sale | 1,750 | 30.00 | 52,500 |
| 2020-09-29 | Smither John W (Chief Financial Officer) | Option Ex | 500 | 1.68 | 840 |
| 2020-09-29 | Osborne David W (Chief Technical Officer) | Sale | 15,000 | 30.00 | 450,000 |
| 2020-09-15 | Welgus Howard G. | Option Ex | 1,222 | .58 | 708 |
| 2020-09-01 | Welgus Howard G. | Sale | 2,200 | 24.38 | 53,642 |
| 2020-09-01 | Welgus Howard G. | Option Ex | 2,200 | 1.68 | 3,696 |
| 2020-08-20 | Welgus Howard G. | Option Ex | 5,000 | 1.68 | 8,400 |
| 2020-08-18 | Welgus Howard G. | Option Ex | 5,076 | 1.68 | 8,527 |
| 2020-08-14 | Welgus Howard G. | Option Ex | 6,110 | .58 | 3,543 |
| 2020-08-03 | Welgus Howard G. | Sale | 2,800 | 25.63 | 71,764 |
| 2020-08-03 | Welgus Howard G. | Option Ex | 2,800 | 1.68 | 4,704 |
| 2020-06-11 | Smither John W (Chief Financial Officer) | Option Ex | 14,875 | 1.68 | 25,004 |
| 2020-03-13 | Watanabe Todd Franklin (President and CEO) | Option Ex | 59,481 | 1.68 | 99,987 |
| 2020-03-12 | Welgus Howard G. (Chief Medical Officer) | Option Ex | 6,110 | .58 | 3,543 |
| 2020-02-04 | Schwartz Jeffrey Lawrence (10% Owner) | Buy | 294,117 | 17.00 | 4,999,989 |
| 2020-02-04 | Heron Patrick J (Director) | Buy | 500,000 | 17.00 | 8,500,000 |
| 2020-02-04 | Topper James N (10% Owner) | Buy | 500,000 | 17.00 | 8,500,000 |
| 2020-02-03 | Orbimed Capital Gp Vii Llc | Buy | 558,888 | 17.00 | 9,501,096 |
| 2020-02-03 | Silverstein Jonathan | Buy | 558,888 | 17.00 | 9,501,096 |
Insider trading activities including stock purchases, stock sales, and option exercises of ARQT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Arcutis Biotherapeutics, Inc. (symbol ARQT, CIK number 1787306) see the Securities and Exchange Commission (SEC) website.